Micron Beats, Semaglutide Combo, Gemini Doubts (+5 more stories)

The Daily Business & Finance Show · Oct 1, 2026 · 9m

The Daily Business and Finance Show - Thursday, 1 October 2026

We get our business and finance news from Seeking Alpha and you should too! Subscribe to Seeking Alpha Premium for more in-depth market news and help support this podcast. Free for 14-days!

Please click here for more info: Subscribe to Seeking Alpha Premium News

Today's headlines:

Micron rises as Q4 results, guidance top estimates

Regeneron drug said to cut muscle loss when combined with Novo's semaglutide

Google reportedly faces internal doubts over Gemini 4 performance

3 things to look out for on Thursday

House Democrats seek…